InvestorsHub Logo
Followers 1
Posts 77
Boards Moderated 0
Alias Born 12/08/2011

Re: microbe_man post# 213887

Tuesday, 03/31/2015 2:20:53 PM

Tuesday, March 31, 2015 2:20:53 PM

Post# of 346056

Wrong study to use, It is 34% and 6.3 months

J Clin Oncol. 2003 Feb 15;21(4):588-92.
Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193).
Sledge GW1, Neuberg D, Bernardo P, Ingle JN, Martino S, Rowinsky EK, Wood WC.



Even better to compare and beat a Front-line study!!!
I know it is a small IST but I hope(hopeX2)we at least try for a BTD!

MG
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News